Tissue Regenix to relocate its Leeds head office and manufacturing base

The regenerative medical devices company is to move its head office and manufacturing facilities to Garforth, Leeds, in November 2020.

The strategic decision to relocate the Company's UK operations from nearby Swillington, Leeds, was made as part of the ongoing overhead cost saving initiatives being implemented by Tissue Regenix and is expected to reduce the Group's overhead spend by over £400,000 on an annualised basis from 2021.

As part of the relocation programme, the Group will outsource elements of the production cycle relating to testing and packaging, but will retain its processing capabilities including the manufacturing of OrthoPure XT.

"Following a review of our near-term activity, this relocation will allow us to reduce our manufacturing footprint and associated costs, whilst importantly protecting the supply of our products.

"We also remain within the Leeds and York area to continue to support our local community and retain our valuable employee base. I am pleased we have successfully identified an action plan that addresses these criteria."